Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients

Cell Reports Medicine - Tập 1 Số 3 - Trang 100040 - 2020
Mehul S. Suthar1,2,3,4, Matthew G. Zimmerman1,2,3,4, Robert C. Kauffman1,2,3, Grace Mantus1,2,3, Susanne L. Linderman5,3, William Henry Hudson5,3, Abigail Vanderheiden1,2,3,4, Lindsay E. Nyhoff1,2,3, Carl W. Davis5,3, Oluwaseyi Adekunle1,2,3, Maurizio Affer1,2,3, Melanie Sherman6, Stacian Reynolds6, Hans P. Verkerke7, David Alter7, Jeannette Guarner7, Janetta Bryksin7, Michael Horwath7, Connie M. Arthur7, Natia Saakadze7, Geoffrey H. Smith7, Srilatha Edupuganti8,9, Erin M. Scherer8,9, Kieffer Hellmeister8,9, Andrew Cheng8,9, Juliet Morales8,9, Andrew S. Neish7, Sean R. Stowell7, Filipp Frank10, Eric A. Ortlund10, Evan J. Anderson1,2, Vineet D. Menachery11, Nadine Rouphael8,9, Aneesh K. Mehta8, David S. Stephens8, Rafi Ahmed5,3, John D. Roback7, Jens Wrammert1,2,3
1Center for Childhood Infections and Vaccines
2Children's Healthcare of Atlanta and Emory University Department of Pediatrics, Atlanta, GA 30322, USA
3Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30329, USA
4Yerkes National Primate Research Center, Atlanta, GA 30329, USA
5Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA
6Emory Medical Laboratories, Emory Healthcare, Atlanta, GA 30322, USA
7Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA
8Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
9Hope Clinic of the Emory Vaccine Center, Emory University School of Medicine Decatur, Atlanta, GA, USA
10Department of Biochemistry, Emory University School of Medicine, Atlanta, GA, USA
11Department of Microbiology and Immunology, Institute for Human Infection and Immunity, World Reference Center for Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, TX, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Bolles, 2011, SARS-CoV and emergent coronaviruses: viral determinants of interspecies transmission, Curr. Opin. Virol., 1, 624, 10.1016/j.coviro.2011.10.012

Deming, 2006, Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants, PLoS Med., 3, e525, 10.1371/journal.pmed.0030525

Buchholz, 2004, Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity, Proc. Natl. Acad. Sci. USA, 101, 9804, 10.1073/pnas.0403492101

Bosch, 2003, The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex, J. Virol., 77, 8801, 10.1128/JVI.77.16.8801-8811.2003

Hoffmann, 2020, SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor, Cell, 181, 271, 10.1016/j.cell.2020.02.052

Wang, 2020, Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2, Cell, 181, 894, 10.1016/j.cell.2020.03.045

Tortorici, 2019, Structural insights into coronavirus entry, Adv. Virus Res., 105, 93, 10.1016/bs.aivir.2019.08.002

Li, 2005, Structure of SARS coronavirus spike receptor-binding domain complexed with receptor, Science, 309, 1864, 10.1126/science.1116480

Lu, 2013, Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26, Nature, 500, 227, 10.1038/nature12328

Walls, 2020, Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein, Cell, 181, 281, 10.1016/j.cell.2020.02.058

ter Meulen, 2006, Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants, PLoS Med., 3, e237, 10.1371/journal.pmed.0030237

Harcourt, 2020, Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States, Emerg. Infect. Dis., 26, 1266, 10.3201/eid2606.200516

Rockx, 2008, Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge, J. Virol., 82, 3220, 10.1128/JVI.02377-07

Lee, 2020, Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients, J. Infect., 10.1016/j.jinf.2020.04.019

Okba, 2020, Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients, Emerg. Infect. Dis., 26, 9, 10.3201/eid2607.200841

Bloch, 2020, Deployment of convalescent plasma for the prevention and treatment of COVID-19, J. Clin. Invest., 130, 2757, 10.1172/JCI138745

Shen, 2020, Treatment of 5 Critically Ill Patients with COVID-19 with Convalescent Plasma, JAMA, 323, 1582, 10.1001/jama.2020.4783

Liu, 2006, Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome, J. Infect. Dis., 193, 792, 10.1086/500469

Amanat, 2020, SARS-CoV-2 Vaccines: Status Report, Immunity, 52, 583, 10.1016/j.immuni.2020.03.007

Smith, 2009, Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen, Nat. Protoc., 4, 372, 10.1038/nprot.2009.3

Wrapp, 2020, Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation, Science, 367, 1260, 10.1126/science.abb2507